Search research articles
Contact Us
Filters
Showing results (1-10 of 24) with videos related to
Page
of 3
Sort By:
Carcinogenesis
|
July 27, 2010
Resistance to transforming growth factor β-mediated tumor suppression in melanoma: are multiple mechanisms in place?
Ahmed Lasfar, Karine A Cohen-Solal
Drug Discovery Today
|
November 11, 2015
IFN-lambda therapy: current status and future perspectives
Ahmed Lasfar, Andrew Zloza, Karine A Cohen-Solal
Molecular Cancer
|
July 25, 2015
RUNX2 and the PI3K/AKT axis reciprocal activation as a driving force for tumor progression
Karine A Cohen-Solal, Rajeev K Boregowda, Ahmed Lasfar
Pigment Cell & Melanoma Research
|
November 2, 2017
Transcription factors as critical players in melanoma invasiveness, drug resistance, and opportunities for therapeutic drug development
Karine A Cohen-Solal, Howard L Kaufman, Ahmed Lasfar
Frontiers in Oncology
|
December 5, 2019
Editorial: Tumor Microenvironment and Resistance to Current Therapies
Ahmed Lasfar, Murugabaskar Balan, Karine A Cohen-Solal, et al.
Clinical & Developmental Immunology
|
December 23, 2011
Interferon lambda: a new sword in cancer immunotherapy
Ahmed Lasfar, Walid Abushahba, Murugabaskar Balan, et al.
Immunotherapy
|
July 7, 2016
IFN-λ cancer immunotherapy: new kid on the block
Ahmed Lasfar, Helen Gogas, Andrew Zloza, et al.
Frontiers in Immunology
|
December 27, 2016
IFN-λ: A New Inducer of Local Immunity against Cancer and Infections
Ahmed Lasfar, Andrew Zloza, Andrew de la Torre, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
July 19, 2018
Interferon Lambda: Toward a Dual Role in Cancer
Ahmed Lasfar, Andrew Zloza, Ann W Silk, et al.
Cytokine
|
December 28, 2020
Cytokine storm induced by SARS-CoV-2 infection: The spectrum of its neurological manifestations
Parisorn Thepmankorn, John Bach, Ahmed Lasfar, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 24) with videos related to
Sort By:
Page
of 3
Carcinogenesis
|
July 27, 2010
Resistance to transforming growth factor β-mediated tumor suppression in melanoma: are multiple mechanisms in place?
Ahmed Lasfar, Karine A Cohen-Solal
Drug Discovery Today
|
November 11, 2015
IFN-lambda therapy: current status and future perspectives
Ahmed Lasfar, Andrew Zloza, Karine A Cohen-Solal
Molecular Cancer
|
July 25, 2015
RUNX2 and the PI3K/AKT axis reciprocal activation as a driving force for tumor progression
Karine A Cohen-Solal, Rajeev K Boregowda, Ahmed Lasfar
Pigment Cell & Melanoma Research
|
November 2, 2017
Transcription factors as critical players in melanoma invasiveness, drug resistance, and opportunities for therapeutic drug development
Karine A Cohen-Solal, Howard L Kaufman, Ahmed Lasfar
Frontiers in Oncology
|
December 5, 2019
Editorial: Tumor Microenvironment and Resistance to Current Therapies
Ahmed Lasfar, Murugabaskar Balan, Karine A Cohen-Solal, et al.
Clinical & Developmental Immunology
|
December 23, 2011
Interferon lambda: a new sword in cancer immunotherapy
Ahmed Lasfar, Walid Abushahba, Murugabaskar Balan, et al.
Immunotherapy
|
July 7, 2016
IFN-λ cancer immunotherapy: new kid on the block
Ahmed Lasfar, Helen Gogas, Andrew Zloza, et al.
Frontiers in Immunology
|
December 27, 2016
IFN-λ: A New Inducer of Local Immunity against Cancer and Infections
Ahmed Lasfar, Andrew Zloza, Andrew de la Torre, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
July 19, 2018
Interferon Lambda: Toward a Dual Role in Cancer
Ahmed Lasfar, Andrew Zloza, Ann W Silk, et al.
Cytokine
|
December 28, 2020
Cytokine storm induced by SARS-CoV-2 infection: The spectrum of its neurological manifestations
Parisorn Thepmankorn, John Bach, Ahmed Lasfar, et al.
Page
of 3